Annual Current Ratio
5.45
+3.98+270.75%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual current ratio is 5.45, with the most recent change of +3.98 (+270.75%) on December 31, 2023.
- During the last 3 years, SABS annual current ratio has risen by +2.34 (+75.24%).
- SABS annual current ratio is now at all-time high.
Performance
SABS Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
3.69
-1.55-29.58%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly current ratio is 3.69, with the most recent change of -1.55 (-29.58%) on September 30, 2024.
- Over the past year, SABS quarterly current ratio has increased by +3.35 (+985.29%).
- SABS quarterly current ratio is now -34.69% below its all-time high of 5.65, reached on March 31, 2024.
Performance
SABS Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
SABS Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +270.8% | +985.3% |
| 3 y3 years | +75.2% | +183.8% |
| 5 y5 years | +171.1% | +183.8% |
SABS Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +270.8% | -34.7% | +985.3% |
| 5 y | 5-year | at high | +270.8% | -34.7% | +985.3% |
| alltime | all time | at high | +270.8% | -34.7% | +985.3% |
SAB Biotherapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 3.69(-29.6%) |
| Jun 2024 | - | 5.24(-7.3%) |
| Mar 2024 | - | 5.65(+3.7%) |
| Dec 2023 | 5.45(+270.7%) | 5.45(+1502.9%) |
| Sep 2023 | - | 0.34(-58.5%) |
| Jun 2023 | - | 0.82(-25.5%) |
| Mar 2023 | - | 1.10(-25.2%) |
| Dec 2022 | 1.47 | 1.47(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 1.30(-24.4%) |
| Jun 2022 | - | 1.72(-13.1%) |
| Mar 2022 | - | 1.98(+4.2%) |
| Dec 2021 | 1.90(-38.9%) | 1.90(-20.5%) |
| Sep 2021 | - | 2.39(-12.1%) |
| Jun 2021 | - | 2.72(-12.5%) |
| Dec 2020 | 3.11(+54.7%) | 3.11 |
| Dec 2019 | 2.01 | - |
FAQ
- What is SAB Biotherapeutics annual current ratio?
- What is the all time high annual current ratio for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual current ratio year-on-year change?
- What is SAB Biotherapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly current ratio year-on-year change?
What is SAB Biotherapeutics annual current ratio?
The current annual current ratio of SABS is 5.45
What is the all time high annual current ratio for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual current ratio is 5.45
What is SAB Biotherapeutics annual current ratio year-on-year change?
Over the past year, SABS annual current ratio has changed by +3.98 (+270.75%)
What is SAB Biotherapeutics quarterly current ratio?
The current quarterly current ratio of SABS is 3.69
What is the all time high quarterly current ratio for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly current ratio is 5.65
What is SAB Biotherapeutics quarterly current ratio year-on-year change?
Over the past year, SABS quarterly current ratio has changed by +3.35 (+985.29%)